首页>
外国专利>
THERAPEUTIC SURROGATE END POINT FOR ANTI-CTLA-4 BASED IMMUNTERAPY OF DISEASE
THERAPEUTIC SURROGATE END POINT FOR ANTI-CTLA-4 BASED IMMUNTERAPY OF DISEASE
展开▼
机译:基于抗CTLA-4的疾病的治疗性替代终点
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides a method of treatment using human sequence antibodies against human CTLA-4. In particular, methods of treating cancer are provided.
展开▼